ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 25 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,000 | -53.8% | 24,150 | -50.9% | 0.00% | -57.1% |
| Q2 2020 | $78,000 | +239.1% | 49,150 | +103.5% | 0.01% | +133.3% |
| Q1 2020 | $23,000 | -83.2% | 24,150 | -51.8% | 0.00% | -75.0% |
| Q4 2019 | $137,000 | +35.6% | 50,150 | +95.5% | 0.01% | +20.0% |
| Q3 2019 | $101,000 | +60.3% | 25,650 | +66.6% | 0.01% | +66.7% |
| Q2 2019 | $63,000 | – | 15,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |